COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.

导出 OA

翻译打印收藏纠错

作者： Martin,Cornillet ^[1] ; Benedikt,Strunz ^[1] ; Olav,Rooyackers ^[2] ; Andrea,Ponzetta ^[1] ; Puran,Chen ^[1] ; Jagadeeswara Rao,Muvva ^[1] ; Mira,Akber ^[1] ; Marcus,Buggert ^[1] ; Benedict J,Chambers ^[1] ; Majda,Dzidic ^[1] ; Iva,Filipovic ^[1] ; Jean-Baptiste,Gorin ^[1] ; Sara,Gredmark-Russ ^[1] ; Laura,Hertwig ^[3] ; Jonas,Klingström ^[1] ; Efthymia,Kokkinou ^[1] ; Egle,Kvedaraite ^[1] ; Magda,Lourda ^[1] ; Jenny,Mjösberg ^[4] ; Christopher,Maucourant ^[1] ; Anna,Norrby-Teglund ^[1] ; Tiphaine,Parrot ^[1] ; André,Perez-Potti ^[1] ; Olga,Rivera-Ballesteros ^[1] ; Johan K,Sandberg ^[1] ; John Tyler,Sandberg ^[1] ; Takuya,Sekine ^[1] ; Mattias,Svensson ^[1] ; Renata,Varnaite ^[1] ; Karolinska KI/K COVID-19 Study Group ^[1] ; Lars I,Eriksson ^[1] ; Soo,Aleman ^[1] ; Kristoffer,Strålin ^[2] ; Hans-Gustaf,Ljunggren ^[3] ; Niklas K,Björkström ^[3]

作者单位： Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. ^[1] Department of Emergency Medicine, Karolinska University Hospital, Stockholm, Sweden. ^[2] Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. ^[3] Department of Clinical Pathology, Karolinska University Hospital, Stockholm, Sweden. ^[4]

关键词 COVID-19 Metabolomics Multi-omics Multiorgan Neuroinflammation SARS-CoV-2